169 filings
Page 7 of 9
8-K
y80uskir 4e
1 Jun 20
Submission of Matters to a Vote of Security Holders
4:09pm
8-K
e0remgfrsbg57mb
29 May 20
Harpoon Therapeutics Presents Interim Phase 1 Data from an Ongoing Dose
4:03pm
8-K
zgdm3 kdc3r
6 May 20
Harpoon Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update
4:10pm
EFFECT
m05 5sflz
24 Apr 20
Notice of effectiveness
12:15am
CORRESP
p1mwx04x1eaj
21 Apr 20
Correspondence with SEC
12:00am
8-K/A
g7eee4mxf6gmxg8lk8
17 Apr 20
Departure of Directors or Certain Officers
5:15pm
DEFA14A
ik7zyqmzbjn3qh0vh
17 Apr 20
Additional proxy soliciting materials
5:07pm
DEF 14A
6ol2xk wrs
17 Apr 20
Definitive proxy
5:02pm
8-K
68e48c e3ohc
6 Apr 20
Other Events
6:12am
8-K
2frz7h8 ojm
1 Apr 20
Departure of Directors or Certain Officers
5:01pm
UPLOAD
yc2bnmbtqfqlyhlcbvkj
19 Mar 20
Letter from SEC
12:00am
S-3
v4c9xv8rm6o7
13 Mar 20
Shelf registration
4:53pm
S-8
o3w356b9soky
13 Mar 20
Registration of securities for employees
4:50pm
CORRESP
3o6tv
13 Mar 20
Correspondence with SEC
12:00am
8-K
z4kbybsuwt
12 Mar 20
Harpoon Therapeutics Reports Fourth Quarter 2019 Financial Results and Provides Corporate Update
4:11pm
8-K
8u920dwl5hrn1t zyj2
27 Dec 19
Entry into a Material Definitive Agreement
12:00am
8-K
uul6ci4n y0x3
20 Nov 19
Entry into a Material Definitive Agreement
9:56pm